KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lam Research (LRCX) Research & Development (2016 - 2025)

Historic Research & Development for Lam Research (LRCX) over the last 17 years, with Q4 2025 value amounting to $573.3 million.

  • Lam Research's Research & Development rose 1583.16% to $573.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 1276.86%. This contributed to the annual value of $2.1 billion for FY2025, which is 1019.44% up from last year.
  • As of Q4 2025, Lam Research's Research & Development stood at $573.3 million, which was up 1583.16% from $576.4 million recorded in Q3 2025.
  • Lam Research's Research & Development's 5-year high stood at $580.2 million during Q2 2025, with a 5-year trough of $381.1 million in Q1 2021.
  • Moreover, its 5-year median value for Research & Development was $447.9 million (2022), whereas its average is $462.1 million.
  • As far as peak fluctuations go, Lam Research's Research & Development plummeted by 247.96% in 2023, and later surged by 2385.32% in 2024.
  • Lam Research's Research & Development (Quarter) stood at $403.6 million in 2021, then grew by 14.55% to $462.4 million in 2022, then increased by 1.58% to $469.7 million in 2023, then grew by 5.37% to $494.9 million in 2024, then increased by 15.83% to $573.3 million in 2025.
  • Its Research & Development stands at $573.3 million for Q4 2025, versus $576.4 million for Q3 2025 and $580.2 million for Q2 2025.